Product
Kleb4V
1 clinical trial
1 indication
Indication
Klebsiella pneumoniae infectionClinical trial
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A FTIH Phase I/II Randomized and Controlled StudyStatus: Completed, Estimated PCD: 2022-09-26